The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.
Moderna’s stock jumps after biotech raises sales outlook
The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.
Key Takeaways
- Moderna’s stock jumps after biotech raises sales outlook.
- The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.
- The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.
Read Complete Original Article
Published originally on MarketWatch Top Stories


